Diurnal
Deborah Jorn is the current director at Diurnal. Deborah has held various other positions in the past, including executive vice president and company group chair at Valeant Pharmaceuticals, global vice president of urology at Pharmacia Corporation, and group vice president allergy and respiratory at Schering-Plough. Jorn has also been a member of the board at Orexigen Therapeutics and held the title of VP global marketing at Bausch + Lomb.
Deborah Jorn has a MBA in Marketing & International Business from NYU Stern School of Business and a BA in Biochemistry from Rutgers University.
This person is not in the org chart
This person is not in any teams
This person is not in any offices
Diurnal
Diurnal is a UK-based specialty pharmaceutical company dedicated to developing high-quality hormone therapeutics to aid lifelong treatment for rare and chronic endocrine conditions, including Congenital Adrenal Hyperplasia, Adrenal Insufficiency, Hypog...